China’s Genetics Giant BGI Wants Everyone to Live to at Least 99

The transcript discusses BGI's vision to integrate genomics into medicine, aiming to use genetic information to guide medical decisions. It highlights the ethical and political challenges, such as lack of regulation against DNA-based discrimination and privacy concerns. The financial opacity of BGI and similar Chinese companies is also examined, noting the difficulties in obtaining reliable information and the geopolitical suspicions they face when expanding globally.

What privacy concerns are associated with genome sequencing?

In what ways do the opaque financial structures of Chinese companies impact their international ambitions?